C. R. Pullinger, D. Gaffney, M. M. Gutierrez, M. J. Malloy, V. N. Schumaker et al., The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds, J. Lipid Res, vol.40, pp.318-327, 1999.

M. M. Motazacker, J. Pirruccello, R. Huijgen, R. Do, S. Gabriel et al., Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia, European Heart Journal, vol.33, issue.11, pp.1360-1366, 2012.
DOI : 10.1093/eurheartj/ehs010

E. R. Thomas, S. S. Atanur, P. J. Norsworthy, V. Encheva, A. P. Snijders et al., Identifi cation and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia, 2013.

A. C. Alves, A. Etxebarria, A. K. Soutar, C. Martin, and M. Bourbon, Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia, Human Molecular Genetics, vol.23, issue.7, pp.1817-1828, 2014.
DOI : 10.1093/hmg/ddt573

M. Farnier, PCSK9: From discovery to therapeutic applications, Archives of Cardiovascular Diseases, vol.107, issue.1, pp.58-66, 2014.
DOI : 10.1016/j.acvd.2013.10.007

Y. J. Shimada and C. P. Cannon, PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future, European Heart Journal, vol.36, issue.36, pp.2415-2424, 2015.
DOI : 10.1093/eurheartj/ehv174

D. M. Hatters, C. A. Peters-libeu, and K. H. Weisgraber, Apolipoprotein E structure: insights into function, Trends in Biochemical Sciences, vol.31, issue.8, pp.445-454, 2006.
DOI : 10.1016/j.tibs.2006.06.008

J. E. Eichner, S. T. Dunn, G. Perveau, D. M. Thompson, K. E. Stewart et al., Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review, American Journal of Epidemiology, vol.155, issue.6, pp.487-495, 2002.
DOI : 10.1093/aje/155.6.487

T. A. Khan, T. Shah, D. Prieto, W. Zhang, J. Price et al., Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: Systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals, International Journal of Epidemiology, vol.42, issue.2, pp.475-492, 2013.
DOI : 10.1093/ije/dyt034

R. R. Williams, S. C. Hunt, M. C. Schumacher, R. A. Hegele, M. F. Leppert et al., Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics, The American Journal of Cardiology, vol.72, issue.2, pp.171-176, 1993.
DOI : 10.1016/0002-9149(93)90155-6

J. C. Defesche, Familial hypercholesterolemia, Lipids and Vascular Dunitz, pp.65-76, 2000.

P. Benlian, A. Turquet, F. Carrat, S. Amsellem, L. Sanchez et al., Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia, Journal of Pediatric Gastroenterology and Nutrition, vol.48, issue.4, pp.456-463, 2009.
DOI : 10.1097/MPG.0b013e3181810b30

P. Kumar, S. Hinokoff, and P. C. Ng, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm, Nature Protocols, vol.4, issue.8, pp.1073-1081, 2009.
DOI : 10.1101/gr.772403

I. A. Adzhubei, S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova et al., A method and server for predicting damaging missense mutations, Nature Methods, vol.7, issue.4, pp.248-249, 2010.
DOI : 10.1038/nmeth0410-248

V. Parthiban, M. M. Gromiha, and D. Schomburg, CUPSAT: prediction of protein stability upon point mutations, Nucleic Acids Research, vol.34, issue.Web Server, pp.239-242, 2006.
DOI : 10.1093/nar/gkl190

J. Chen, Q. Li, and J. Wang, Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions, Proc. Natl. Acad. Sci. USA, pp.14813-14818, 2011.
DOI : 10.1007/s10858-011-9526-0

D. Baralle and M. Baralle, Splicing in action: assessing disease causing sequence changes, Journal of Medical Genetics, vol.42, issue.10, pp.737-748, 2005.
DOI : 10.1136/jmg.2004.029538

H. Crehalet, P. Latour, V. Bonnet, S. Attarian, P. Labauge et al., U1 snRNA mis-binding: a new cause of CMT1B, neurogenetics, vol.111, issue.5, pp.13-19, 2010.
DOI : 10.1007/BF00206959

G. Millat, E. Lafont, S. Nony, I. Rouvet, and D. Bozon, Functional Characterization of Putative Novel Splicing Mutations in the Cardiomyopathy-Causing Genes, DNA and Cell Biology, vol.34, issue.7, pp.489-496, 2015.
DOI : 10.1089/dna.2015.2842

B. G. Nordestgaard, M. J. Chapman, S. E. Humphries, H. N. Ginsberg, L. Masana et al., Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society, European Heart Journal, vol.34, issue.45, pp.3478-3490
DOI : 10.1093/eurheartj/eht273

M. Varret, M. Abifadel, J. P. Rabès, and C. Boileau, Genetic heterogeneity of autosomal dominant hypercholesterolemia, Clinical Genetics, vol.6, issue.2, pp.1-13, 2008.
DOI : 10.1161/01.ATV.17.4.741

M. Futema, V. Plagnol, K. Li, R. A. Whittall, H. A. Neil et al., mutations, Journal of Medical Genetics, vol.45, issue.8, pp.537-544, 2014.
DOI : 10.1038/ng.2797

M. Marduel, K. Ouguerram, V. Serre, D. Bonnefont-rousselot, A. Marques-pinheiro et al., p.Leu167del Mutation, Human Mutation, vol.257, issue.2, pp.83-87, 2013.
DOI : 10.1007/s11883-001-0061-4

Z. Awan, H. Y. Choi, N. Stitziel, I. Ruel, M. A. Bamimore et al., APOE p.Leu167del mutation in familial hypercholesterolemia, Atherosclerosis, vol.231, issue.2, pp.218-222, 2013.
DOI : 10.1016/j.atherosclerosis.2013.09.007

D. B. Miller, R. A. Hegele, B. M. Wolfe, and M. W. Huff, Identifi cation, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia, J. Clin. Endocrinol. Metab, vol.80, pp.807-813, 1995.

M. Solanas-barca, I. De-castro-orós, R. Mateo-gallego, M. Cof-Áá-n, N. Plana et al., Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia, Atherosclerosis, vol.222, issue.2, pp.449-455, 2012.
DOI : 10.1016/j.atherosclerosis.2012.03.011

O. Guardamagna, G. Restagno, E. Rolfo, C. Pederiva, S. Martini et al., The Type of LDLR Gene Mutation Predicts Cardiovascular Risk in Children with Familial Hypercholesterolemia, The Journal of Pediatrics, vol.155, issue.2, pp.199-204, 2009.
DOI : 10.1016/j.jpeds.2009.02.022

M. Marduel, A. Carrié, A. Sassolas, M. Devillers, V. Carreau et al., Molecular Spectrum of Autosomal Dominant Hypercholesterolemia in France, Human Mutation, vol.31, issue.11, pp.1811-1824, 2010.
DOI : 10.1002/humu.21348

URL : https://hal.archives-ouvertes.fr/hal-00573066

A. Van-der-graaf, H. J. Avis, D. M. Kusters, M. N. Vissers, B. A. Hutten et al., Molecular Basis of Autosomal Dominant Hypercholesterolemia: Assessment in a Large Cohort of Hypercholesterolemic Children, Circulation, vol.123, issue.11, pp.1167-1173, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.979450

A. M. Medeiros, A. C. Alves, and M. Bourbon, Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement, Genetics in Medicine, vol.7, issue.4, 2015.
DOI : 10.1258/jrsm.97.5.226

S. Amsellem, D. Briffaut, A. Carrié, J. P. Rabès, J. P. Girardet et al., Intronic mutations outside of Alu -repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia, Human Genetics, vol.111, issue.6, pp.501-510, 2002.
DOI : 10.1007/s00439-002-0813-4

A. J. Whitfi-eld, P. H. Barrett, F. M. Van-bockxmeer, and J. R. Burnett, Lipid Disorders and Mutations in the APOB Gene, Clinical Chemistry, vol.50, issue.10, pp.1725-1732, 2004.
DOI : 10.1373/clinchem.2004.038026

J. Borén, U. Ekström, B. Agren, P. Nilsson-ehle, and T. L. Innerarity, The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100, Journal of Biological Chemistry, vol.256, issue.12, pp.9214-9218, 2001.
DOI : 10.1172/JCI5549

D. Gaffney, J. M. Reid, I. M. Cameron, K. Vass, M. J. Caslake et al., Independent mutations at codon 37 Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate, Atherosclerosis, vol.182, pp.331-340, 1995.

D. J. Barlow and J. M. Thornton, Helix geometry in proteins, Journal of Molecular Biology, vol.201, issue.3, pp.601-619, 1988.
DOI : 10.1016/0022-2836(88)90641-9

L. Argyri, I. Dafnis, T. A. Theodossiou, D. Gantz, E. Stratikos et al., Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4, Journal of Biological Chemistry, vol.1768, issue.18, pp.12931-12945, 2014.
DOI : 10.1073/pnas.95.18.10914

S. W. Fouchier, G. M. Dallinga-thie, J. C. Meijers, N. Zelcer, J. J. Kastelein et al., Mutations in STAP1 Are Associated With Autosomal Dominant Hypercholesterolemia, Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia, pp.552-555, 2014.
DOI : 10.1161/CIRCRESAHA.115.304660

A. Marques-pinheiro, M. Marduel, J. P. Rabès, M. Devillers, L. Villéger et al., A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1, European Journal of Human Genetics, vol.73, issue.11, pp.1236-1242
DOI : 10.1016/S1388-1981(01)00187-1

URL : https://hal.archives-ouvertes.fr/hal-00549893

R. W. Mahley, K. H. Weisgraber, and Y. Huang, Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS, Journal of Lipid Research, vol.40, issue.Supplement, pp.183-188, 2009.
DOI : 10.1097/00041433-199906000-00003

B. Sjouke, D. M. Kusters, I. Kindt, J. Besseling, J. C. Defesche et al., Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype???phenotype relationship, and clinical outcome, European Heart Journal, vol.36, issue.9, pp.560-565, 2014.
DOI : 10.1093/eurheartj/ehu058

M. Zaiou, K. S. Arnold, Y. M. Newhouse, T. L. Innerarity, K. H. Weisgraber et al., Apolipoprotein E-low density lipoprotein receptor interaction: infl uences of basic residue and amphipathic alpha-helix organization in the ligand, J. Lipid Res, vol.41, pp.1087-1095, 2000.

K. H. Weisgraber, T. L. Innerarity, and R. W. Mahley, Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site, 1982.

P. J. Kraulis, MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures, Journal of Applied Crystallography, vol.24, issue.5, pp.946-950, 1991.
DOI : 10.1107/S0021889891004399

E. A. Merritt and D. J. Bacon, Raster3D: photorealistic molecular graphics www.jlr.org Downloaded from, P055699.DC1 Supplemental Material can be found at, pp.505-524, 1997.
DOI : 10.1016/s0076-6879(97)77028-9